<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>403</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10196124</PubmedId>
            <Abstract>BACKGROUND: Camelid serum contains a large fraction of functional heavy-chain antibodies - homodimers of heavy chains without light chains. The variable domains of these heavy-chain antibodies (VHH) have a long complementarity determining region 3 (CDR3) loop that compensates for the absence of the antigen-binding loops of the variable light chains (VL). In the case of the VHH fragment cAb-Lys3, part of the 24 amino acid long CDR3 loop protrudes from the antigen-binding surface and inserts into the active-site cleft of its antigen, rendering cAb-Lys3 a competitive enzyme inhibitor. RESULTS: Camelid serum contains a large fraction of functional heavy-chain antibodies - homodimers of heavy chains without light chains. The variable domains of these heavy-chain antibodies (VHH) have a long complementarity determining region 3 (CDR3) loop that compensates for the absence of the antigen-binding loops of the variable light chains (VL). In the case of the VHH fragment cAb-Lys3, part of the 24 amino acid long CDR3 loop protrudes from the antigen-binding surface and inserts into the active-site cleft of its antigen, rendering cAb-Lys3 a competitive enzyme inhibitor.A dromedary VHH with specificity for bovine RNase A, cAb-RN05, has a short CDR3 loop of 12 amino acids and is not a competitive enzyme inhibitor. The structure of the cAb-RN05-RNase A complex has been solved at 2.8 A. The VHH scaffold architecture is close to that of a human VH (variable heavy chain). The structure of the antigen-binding hypervariable 1 loop (H1) of both cAb-RN05 and cAb-Lys3 differ from the known canonical structures; in addition these H1 loops resemble each other. The CDR3 provides an antigen-binding surface and shields the face of the domain that interacts with VL in conventional antibodies. CONCLUSIONS: Camelid serum contains a large fraction of functional heavy-chain antibodies - homodimers of heavy chains without light chains. The variable domains of these heavy-chain antibodies (VHH) have a long complementarity determining region 3 (CDR3) loop that compensates for the absence of the antigen-binding loops of the variable light chains (VL). In the case of the VHH fragment cAb-Lys3, part of the 24 amino acid long CDR3 loop protrudes from the antigen-binding surface and inserts into the active-site cleft of its antigen, rendering cAb-Lys3 a competitive enzyme inhibitor.A dromedary VHH with specificity for bovine RNase A, cAb-RN05, has a short CDR3 loop of 12 amino acids and is not a competitive enzyme inhibitor. The structure of the cAb-RN05-RNase A complex has been solved at 2.8 A. The VHH scaffold architecture is close to that of a human VH (variable heavy chain). The structure of the antigen-binding hypervariable 1 loop (H1) of both cAb-RN05 and cAb-Lys3 differ from the known canonical structures; in addition these H1 loops resemble each other. The CDR3 provides an antigen-binding surface and shields the face of the domain that interacts with VL in conventional antibodies.VHHs adopt the common immunoglobulin fold of variable domains, but the antigen-binding loops deviate from the predicted canonical structure. We define a new canonical structure for the H1 loop of immunoglobulins, with cAb-RN05 and cAb-Lys3 as reference structures. This new loop structure might also occur in human or mouse VH domains. Surprisingly, only two loops are involved in antigen recognition; the CDR2 does not participate. Nevertheless, the antigen binding occurs with nanomolar affinities because of a preferential usage of mainchain atoms for antigen interaction.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>361-70</ArticlePages>
            <ArticleTitle>A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Decanniere</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Desmyter</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Lauwereys</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Ghahroudi</LastName>
                    <ForeName>M A</ForeName>
                </Author>
                <Author>
                    <LastName>Muyldermans</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Wyns</LastName>
                    <ForeName>L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratorium voor Ultrastructuur, Vlaams Interuniversitair Instituut voor Biotechnologie, Vrije Universiteit Brussel, Paardenstraat 65, B-1640 St. Genesius-Rode, Belgium. klaas@ultr.vub.ac.be.</Affiliations>
            <ArticleChemicalList>Antigen-Antibody Complex;Immunoglobulin Heavy Chains;Ribonuclease, Pancreatic</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibody Affinity; Antibody Specificity; Antigen-Antibody Complex(chemistry); Antigen-Antibody Reactions; Binding Sites, Antibody; Camelus(immunology); Cattle; Crystallography, X-Ray; Humans; Immunoglobulin Heavy Chains(chemistry; immunology); Mice; Models, Molecular; Molecular Sequence Data; Pancreas(enzymology); Protein Conformation; Ribonuclease, Pancreatic(chemistry; immunology); Software; Species Specificity</ArticleMeshHeadingsList>
            <Journal>
                <Volume>7</Volume>
                <Issue>4</Issue>
                <Title>Structure (London, England : 1993)</Title>
                <Issn>1878-4186</Issn>
                <MedlineTa>Structure</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>cAb-RN05 VHH epitope of RNase A</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>Q86, N88, T96, Y99, E137, G138, Y141</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P61823.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9913</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>77277</EpitopeId>
                <ReferenceRegion>Q60, N62, T70, Y73, E111, G112, Y115</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 1, 3, Figures 2, 3, 4, 7 and PDB 1BZQ</LocationOfData>
                        <BCellId>965</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9838</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P61823.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9913</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Ribonuclease pancreatic precursor</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The antibody was derived from a phage-displayed library of VHH genes constructed using lymphocytes from an immunized camel and selected for binding to RNase A. The VHH protein was expressed in bacteria and purified.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.8</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of VHH cAb-RN05 on RNase A was determined from the crystal structure, solved by molecular replacement.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Displayed Ab(s)</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>VH Domain</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>cAb-RN05</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>Heavy Isotype n/s</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>cAb-RN05</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1BZQ_K</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9838</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <SourceOrganismId>9838</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>RNase A</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P61823.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9913</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1BZQ</ComplexPdbId>
                            <AntibodyChain1PdbChain>L</AntibodyChain1PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>A: Q60, N62, T70, Y73, E111, G112, Y115</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>L: Y1027:H1, Y1031:H1, I1032:H1, Y1033:H1, G1099:H3, G1100:H3, Y1101:H3, R1106:H3, T1107:H3, G1109:H3</AntibodyResiduesInteractingWithAntigen>
                                <InteractingAtomPairs>&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;dataroot xmlns:od="urn:schemas-microsoft-com:officedata" generated="2005-04-11T23:10:20"&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;1&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;Q (Gln)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;60&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;O&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Y (Tyr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1027&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OH&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;2&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;N (Asn)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;62&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;N&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Y (Tyr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1027&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OH&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;3&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;N (Asn)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;62&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;OD1&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;I (Ile)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1032&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;N&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;4&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;Y (Tyr)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;73&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;OH&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;G (Gly)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1099&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;O&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;5&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;T (Thr)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;70&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;OG1&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;G (Gly)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1100&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;O&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;6&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;G (Gly)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;112&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;N&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;R (Arg)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1106&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;O&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;7&lt;/AtomPairID&gt;
&lt;BindingID&gt;40&lt;/BindingID&gt;
&lt;PDB_ID&gt;1bzq&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;A&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;Y (Tyr)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;115&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;OH&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;L&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;T (Thr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;1107&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;O&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;/dataroot&gt;</InteractingAtomPairs>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: Q60, K61, N62, V63, Q69, T70, N71, Y73, Y76, E111, G112, Y115</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>L: Y1027, Y1029, Y1031, I1032, Y1033, G1099, G1100, Y1101, R1104, R1106, T1107, Y1108, G1109</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>541.4</ContactAreaForAntigen>
                                <ContactAreaForAntibody>558.4</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

